Pentazocine-Suppository Paracetamol Versus Pentazocine-Suppository Diclofenac for Post-Caesarean Section Pain Relief: A Randomized Controlled Trial
- Conditions
- Post-Caesarean section pain relief.
- Registration Number
- PACTR202407781417769
- Lead Sponsor
- MODUPEOLA IBRAHIM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 288
All consenting parturient aged 18 years and above scheduled for elective or emergency Caesarean section under regional anesthesia
1.History of peptic ulcer disease
2.Patients who had Caesarean delivery under general anesthesia
3.History of hypersensitivity reaction to pentazocine, paracetamol or diclofenac
4.Severe Pre-eclampsia/Eclampsia
5.Renal and hepatic dysfunction
6.Patients who develop postoperative complications such as PPH
7.Any patient that will require special post-delivery pain control, such as sickle cell disease patients
8.Unconscious patient (GCS <=7)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.